InflaRx N.V.
IFRXNASDAQHealthcare● Active
$1.71
$-0.13(-7.07%)
Market Cap$123519376
P/E Ratio—
52W High$2.949
52W Low$0.741
InflaRx N.V. (IFRX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IFRX · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$0.09
Est. -$0.17 · +47.1%
Revenue
—
Est. $0.00B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS🔥 6-Quarter EPS Beat Streak
IFRX reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.06
Rev. $1.94B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.06
Rev. Est.$1.94B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$0.09 | — | — | — | $0.00B | — |
| ▲ Q2 FY2026 | May 7, 2026 | -$0.17 | -$0.09 | +47.1% | — | $0.00B | — |
| ▲ Q1 FY2026 | Mar 19, 2026 | -$0.18 | -$0.17 | +5.6% | $-0.00B | $0.00B | -164.5% |
| — Q4 FY2025 | Nov 10, 2025 | -$0.16 | -$0.16 | +0.0% | $0.00B | $0.00B | +6.7% |
| — Q3 FY2025 | Aug 7, 2025 | -$0.24 | -$0.24 | +0.0% | $0.00B | $0.00B | +78.6% |
| ▲ Q2 FY2025 | May 7, 2025 | -$0.18 | -$0.14 | +22.2% | — | $0.00B | — |
| ▲ Q1 FY2025 | Mar 20, 2025 | -$0.27 | -$0.09 | +66.7% | $-0.00B | $0.00B | -100.9% |
| ▼ Q4 FY2024 | Nov 8, 2024 | -$0.27 | -$0.33 | -22.2% | $0.00B | $0.00B | +1.9% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$0.09
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
-$0.09
EPS Est.
-$0.17
EPS Surpr.
+47.1%
Revenue
—
Q1 FY2026
Mar 19, 2026Beat
EPS Actual
-$0.17
EPS Est.
-$0.18
EPS Surpr.
+5.6%
Revenue
$-0.00B
Q4 FY2025
Nov 10, 2025
EPS Actual
-$0.16
EPS Est.
-$0.16
EPS Surpr.
+0.0%
Revenue
$0.00B
Q3 FY2025
Aug 7, 2025
EPS Actual
-$0.24
EPS Est.
-$0.24
EPS Surpr.
+0.0%
Revenue
$0.00B
Q2 FY2025
May 7, 2025Beat
EPS Actual
-$0.14
EPS Est.
-$0.18
EPS Surpr.
+22.2%
Revenue
—
Q1 FY2025
Mar 20, 2025Beat
EPS Actual
-$0.09
EPS Est.
-$0.27
EPS Surpr.
+66.7%
Revenue
$-0.00B
Q4 FY2024
Nov 8, 2024Miss
EPS Actual
-$0.33
EPS Est.
-$0.27
EPS Surpr.
-22.2%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.14 | $-0.14 | $-0.14 | 1 |
| Q3 FY2027 | $-0.12 | $-0.12 | $-0.12 | 1 |
| Q2 FY2027 | $-0.11 | $-0.11 | $-0.11 | 1 |
| Q1 FY2027 | $-0.10 | $-0.10 | $-0.10 | 1 |
| Q4 FY2026 | $-0.07 | $-0.07 | $-0.07 | 1 |
| Q3 FY2026 | $-0.09 | $-0.06 | $-0.04 | 3 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 3 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +47.1% | $2.50 | $2.65 | +6.00% |
| ▲ Q1 FY2026 | Mar 19, 2026 | +5.6% | $0.88 | $0.91 | +3.36% |
| ▲ Q4 FY2025 | Nov 10, 2025 | +0.0% | $1.23 | $1.58 | +28.46% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +0.0% | $0.84 | $0.82 | -2.96% |
| ▲ Q2 FY2025 | May 7, 2025 | +22.2% | $1.61 | $1.49 | -7.45% |
| ▲ Q1 FY2025 | Mar 20, 2025 | +66.7% | $1.28 | $1.26 | -1.56% |
| ▼ Q4 FY2024 | Nov 8, 2024 | -22.2% | $1.51 | $1.56 | +3.31% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -23.8% | $1.41 | $1.34 | -4.96% |
Q2 FY2026+6.00%
Report Date
May 7, 2026
EPS Beat/Miss
+47.1%
Price Before
$2.50
Price After
$2.65
Q1 FY2026+3.36%
Report Date
Mar 19, 2026
EPS Beat/Miss
+5.6%
Price Before
$0.88
Price After
$0.91
Q4 FY2025+28.46%
Report Date
Nov 10, 2025
EPS Beat/Miss
+0.0%
Price Before
$1.23
Price After
$1.58
Q3 FY2025-2.96%
Report Date
Aug 7, 2025
EPS Beat/Miss
+0.0%
Price Before
$0.84
Price After
$0.82
Q2 FY2025-7.45%
Report Date
May 7, 2025
EPS Beat/Miss
+22.2%
Price Before
$1.61
Price After
$1.49
Q1 FY2025-1.56%
Report Date
Mar 20, 2025
EPS Beat/Miss
+66.7%
Price Before
$1.28
Price After
$1.26
Q4 FY2024+3.31%
Report Date
Nov 8, 2024
EPS Beat/Miss
-22.2%
Price Before
$1.51
Price After
$1.56
Q3 FY2024-4.96%
Report Date
Aug 8, 2024
EPS Beat/Miss
-23.8%
Price Before
$1.41
Price After
$1.34
Avg Beat Reaction+4.31%
Avg Miss Reaction-0.82%
Beat Rate6 / 8 quarters
Largest Move+28.46% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IFRX ends December
InflaRx N.V. (IFRX) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-0.09 — beating the analyst consensus of $-0.17 by +47.1%. IFRX has beaten EPS estimates for 6 consecutive quarters. The next IFRX earnings date is expected around September 1, 2026.
Each quarter, investors track IFRX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IFRX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IFRX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IFRX earnings · 5 questionsInflaRx N.V.'s next earnings report is expected around September 1, 2026. IFRX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IFRX historically reports after market close (AMC).
IFRX earnings datewhen is IFRX earningsIFRX next earnings datewhen does IFRX report earningsIFRX earnings calendar
▸ Source: FMP · InflaRx N.V. SEC filings · US GAAP · InflaRx N.V. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026